Price loading...

Springer Targeted Cancer Immune Therapy

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Product Description This comprehensive book covers novel immune therapeutic approaches, including cytokine therapy, engineered cell therapy, and the application of tumor-targeted antibodies for generating tumor-specific cell therapy, TLR ligand therapy and cytokine therapy. From the Back Cover Cancer has surpassed heart disease as the number one killer in the world, and standard cancer therapy such as radiation, chemotherapy, and surgery may have reached its plateau in further improving the outcome of treated patients. Biological therapies combined with other treatment approaches may be the next X-factor to greatly extend survival time and improve patients’ quality of life. One of the most developed fields in biological therapy is immune therapy, which has stemmed into many branches due to its significance and the tremendous effort by a large population of scientists. Tumor-targeted antibody therapy has been successfully used for treating some types of tumors, and the first tumor vaccine against ovarian cancer has been developed for clinical application. Targeted Cancer Immune Therapy provides comprehensive coverage of novel immune therapeutic approaches, including cytokine therapy, engineered cell therapy, and the application of tumor-targeted antibodies for generating tumor-specific cell therapy, TLR ligand therapy, and cytokine therapy. In the section "Cytokine Immune Therapy," the authors review relatively new cytokine family members, such as the IL12 family, IL18, IL21, IL24, IL28, and IL29, in regard to the anti-tumor function and application in treating tumors. The strategy for targeting and retaining cytokines in the tumor microenvironment is also reviewed. The section "Cell-based Immune Therapy" focuses on reviewing "state of the art" approaches for engineering potent immune regulatory or effector cells, such as dendritic cells, T cells, and stem cells, for tumor targeting and initiation of tumor specific immune response. In the section "Targeted Immune Therapy," the authors rearticulate antibody therapy for boosting immune response, which includes immunocytokines, "T-body," and tumor targeted CpG ODN. Some or all of these innovative approaches may ultimately become effective future immune therapies for treating malignancy.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
96% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
96% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Springer - Immunotherapy of Cancer: An Innovative Treatment
95% match

Springer - Immunotherapy of Cancer: An Innovative Treatment

Springer

£110.34 18 Apr 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
95% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£129.22 04 Mar 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
95% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£135.04 24 Jan 2026
Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy
95% match

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Springer

£54.12 08 Mar 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
94% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£77.00 24 Feb 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
94% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£78.99 23 Feb 2026
Springer - Resistance to Immunotherapeutic Antibodies in Cancer
94% match

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Springer

£107.61 17 Apr 2026
Clinical Immuno-Oncology
94% match

Clinical Immuno-Oncology

Elsevier

£92.99 25 Jan 2026
Immunopharmacology
94% match

Immunopharmacology

Springer

£92.56 26 Feb 2026
Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation
94% match

Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation

Academic Press

£114.57 18 Apr 2026
Inflammation and Immunity in Cancer
94% match

Inflammation and Immunity in Cancer

Springer

£112.86 08 Mar 2026
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
94% match

Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance

Academic Press

£98.89 09 Mar 2026
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
94% match

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

Academic Press

£90.96 26 Feb 2026
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
94% match

Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors

Springer

£156.60 12 Jan 2026
Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)
94% match

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Springer

£75.84 28 Feb 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
94% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

£110.06 13 Jan 2026
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
94% match

Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)

Springer

£146.40 24 Feb 2026
Cancer Vaccines as Immunotherapy of Cancer
94% match

Cancer Vaccines as Immunotherapy of Cancer

Academic Press

£101.29 08 Mar 2026
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
94% match

Cancer Immunology: Bench to Bedside Immunotherapy of Cancers

Springer

£156.60 11 Jan 2026
Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
94% match

Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)

CRC Press

£79.41 08 Mar 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
94% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£94.01 09 Mar 2026
Cancer and Autoimmunity (Autoanitbody Library)
94% match

Cancer and Autoimmunity (Autoanitbody Library)

Elsevier

£99.60 09 Mar 2026